Works matching IS 00093157 AND DT 2005 AND VI 51 AND IP S1

Results: 15

The Pathogenesis of Gastrointestinal Bacterial Overgrowth.

Published in:

Chemotherapy (0009-3157), 2005, v. 51, n. S1, p. 1, doi. 10.1159/000081988

By:

Husebye, Einar

Publication type:

Article

Foreword / Preface.

Published in:

Chemotherapy (0009-3157), 2005, v. 51, n. S1, p. V, doi. 10.1159/000085479

By:

Gorbach, Sherwood L.;
Scarpignato, Carmelo

Publication type:

Article

Pathophysiology and Impact of Enteric Bacterial and Protozoal Infections: New Approaches to Therapy.

Published in:

Chemotherapy (0009-3157), 2005, v. 51, n. S1, p. 23, doi. 10.1159/000081989

By:

Brito, Gerly A. C.;
Alcantara, Cirle;
Carneiro-Filho, Benedito A.;
Guerrant, Richard L.

Publication type:

Article

Rifaximin, a Poorly Absorbed Antibiotic: Pharmacology and Clinical Potential.

Published in:

Chemotherapy (0009-3157), 2005, v. 51, n. S1, p. 36, doi. 10.1159/000081990

By:

Pelosini, Iva;
Scarpignato, Carmelo

Publication type:

Article

Rifaximin: In vitro and in vivo Antibacterial Activity – A Review.

Published in:

Chemotherapy (0009-3157), 2005, v. 51, n. S1, p. 67, doi. 10.1159/000081991

By:

Jianga, Z. D.;
DuPonta, H. L.

Publication type:

Article

Rifaximin in the Treatment of Infectious Diarrhea.

Published in:

Chemotherapy (0009-3157), 2005, v. 51, n. S1, p. 73, doi. 10.1159/000081992

By:

Ericsson, Charles D.;
DuPont, Herbert L.

Publication type:

Article

Antibiotic-Associated Diarrhea and Pseudomembranous Colitis: Are They Less Common with Poorly Absorbed Antimicrobials?

Published in:

Chemotherapy (0009-3157), 2005, v. 51, n. S1, p. 81, doi. 10.1159/000081993

By:

Surawicz, Christina M.

Publication type:

Article

Rifaximin, a Peculiar Rifamycin Derivative: Established and Potential Clinical Use Outside the Gastrointestinal Tract.

Published in:

Chemotherapy (0009-3157), 2005, v. 51, n. S1, p. 122, doi. 10.1159/000081999

By:

Pelosini, Iva;
Scarpignato, Carmelo

Publication type:

Article

Author Index.

Published in:: Chemotherapy (0009-3157), 2005, v. 51, n. S1, p. 131, doi. 10.1159/000085480
Publication type:: Article

Treatment of Small Intestine Bacterial Overgrowth and Related Symptoms by Rifaximin.

Published in:

Chemotherapy (0009-3157), 2005, v. 51, n. S1, p. 103, doi. 10.1159/000081996

By:

Di Stefano, Michele;
Corazza, Gino Roberto

Publication type:

Article

Management of Diverticular Disease: Is There Room for Rifaximin?

Published in:

Chemotherapy (0009-3157), 2005, v. 51, n. S1, p. 110, doi. 10.1159/000081997

By:

Papi, Claudio;
Koch, Maurizio;
Capurso, Lucio

Publication type:

Article

Mechanical and Antibacterial Bowel Preparation in Colon and Rectal Surgery.

Published in:

Chemotherapy (0009-3157), 2005, v. 51, n. S1, p. 115, doi. 10.1159/000081998

By:

Nichols, Ronald Lee;
Choe, Ella U.;
Weldon, Christopher B.

Publication type:

Article

Management of Hepatic Encephalopathy: Role of Rifaximin.

Published in:

Chemotherapy (0009-3157), 2005, v. 51, n. S1, p. 90, doi. 10.1159/000081994

By:

Zeneroli, Maria Luisa;
Avallone, Rossella;
Corsi, Lorenzo;
Venturini, Ivo;
Baraldi, Claudia;
Baraldi, Mario

Publication type:

Article

Management of Inflammatory Bowel Disease: Does Rifaximin Offer Any Promise?

Published in:

Chemotherapy (0009-3157), 2005, v. 51, n. S1, p. 96, doi. 10.1159/000081995

By:

Gionchetti, Paolo;
Rizzello, Fernando;
Morselli, Claudia;
Romagnoli, Rossella;
Campieri, Massimo

Publication type:

Article

Subject Index.

Published in:: Chemotherapy (0009-3157), 2005, v. 51, n. S1, p. 132, doi. 10.1159/000085481
Publication type:: Article